{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:56:41Z","timestamp":1789646201370,"version":"4.0.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"European Regional Development Fund through COMPETE 2020, together with FCT","award":["PTDC\/MEC-MCI\/29777\/2017"],"award-info":[{"award-number":["PTDC\/MEC-MCI\/29777\/2017"]}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["Program DL 57\/2016 \u2013 Norma transit\u00f3ria"],"award-info":[{"award-number":["Program DL 57\/2016 \u2013 Norma transit\u00f3ria"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/130948\/2017"],"award-info":[{"award-number":["SFRH\/BD\/130948\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["COVID\/BD\/152406\/2022"],"award-info":[{"award-number":["COVID\/BD\/152406\/2022"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/50006\/2020"],"award-info":[{"award-number":["UIDB\/50006\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/50006\/2020"],"award-info":[{"award-number":["UIDP\/50006\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00216-022-04458-w","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T03:02:10Z","timestamp":1670209330000},"page":"683-694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Rapid and sustainable HPLC method for the determination of uremic toxins in human plasma samples"],"prefix":"10.1007","volume":"415","author":[{"given":"Lu\u00eds A. P.","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Campagnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara R.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara S.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3481-5809","authenticated-orcid":false,"given":"Luisa","family":"Barreiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedita","family":"Sampaio-Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela A.","family":"Segundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"issue":"2","key":"4458_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","volume":"19","author":"KA Krautkramer","year":"2021","unstructured":"Krautkramer KA, Fan J, Backhed F. Gut microbial metabolites as multi-kingdom intermediates. Nat Rev Microbiol. 2021;19(2):77\u201394. https:\/\/doi.org\/10.1038\/s41579-020-0438-4.","journal-title":"Nat Rev Microbiol"},{"issue":"21","key":"4458_CR2","doi-asserted-by":"publisher","first-page":"8553","DOI":"10.1074\/jbc.R116.752899","volume":"292","author":"KB Martinez","year":"2017","unstructured":"Martinez KB, Leone V, Chang EB. Microbial metabolites in health and disease: navigating the unknown in search of function. J Biol Chem. 2017;292(21):8553\u20139. https:\/\/doi.org\/10.1074\/jbc.R116.752899.","journal-title":"J Biol Chem"},{"issue":"23","key":"4458_CR3","doi-asserted-by":"publisher","first-page":"12661","DOI":"10.3390\/ijms222312661","volume":"22","author":"DH Yu","year":"2021","unstructured":"Yu DH, Meng X, de Vos WM, Wu H, Fang XX, Maiti AK. Implications of gut microbiota in complex human diseases. Int J Mol Sci. 2021;22(23):12661. https:\/\/doi.org\/10.3390\/ijms222312661.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4458_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/toxins13040252","volume":"13","author":"J Rysz","year":"2021","unstructured":"Rysz J, Franczyk B, Lawinski J, Olszewski R, Cialkowska-Rysz A, Gluba-Brzozka A. The impact of CKD on uremic toxins and gut microbiota. Toxins. 2021;13(4):252. https:\/\/doi.org\/10.3390\/toxins13040252.","journal-title":"Toxins"},{"key":"4458_CR5","first-page":"65","volume-title":"Advances in Applied Microbiology","author":"B Sampaio-Maia","year":"2016","unstructured":"Sampaio-Maia B, Sim\u00f5es-Silva L, Pestana M, Ara\u00fajo R, Soares-Silva IJ. The role of the gut microbiome on chronic kidney disease. In: Sariaslani S, Gadd GM, editors. Advances in Applied Microbiology, vol. 96. Amsterdam: Elsevier; 2016. p. 65\u201394."},{"issue":"12","key":"4458_CR6","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1136\/gutjnl-2019-319766","volume":"69","author":"XF Wang","year":"2020","unstructured":"Wang XF, Yang ST, Li SH, Zhao L, Hao YL, Qin JJ, et al. Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents. Gut. 2020;69(12):2131\u201342. https:\/\/doi.org\/10.1136\/gutjnl-2019-319766.","journal-title":"Gut"},{"issue":"1","key":"4458_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/toxins10010033","volume":"10","author":"R Vanholder","year":"2018","unstructured":"Vanholder R, Pletinck A, Schepers E, Glorieux G. Biochemical and clinical impact of organic uremic retention solutes: a comprehensive update. Toxins. 2018;10(1):1\u201357. https:\/\/doi.org\/10.3390\/toxins10010033.","journal-title":"Toxins"},{"issue":"1","key":"4458_CR8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1053\/j.jrn.2011.10.026","volume":"22","author":"R Vanholder","year":"2012","unstructured":"Vanholder R, Schepers E, Pletinck A, Neirynck N, Glorieux G. An update on protein-bound uremic retention solutes. J Renal Nutr. 2012;22(1):90\u20134. https:\/\/doi.org\/10.1053\/j.jrn.2011.10.026.","journal-title":"J Renal Nutr"},{"issue":"7","key":"4458_CR9","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1681\/asn.2011121175","volume":"23","author":"F Duranton","year":"2012","unstructured":"Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, et al. Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol. 2012;23(7):1258\u201370. https:\/\/doi.org\/10.1681\/asn.2011121175.","journal-title":"J Am Soc Nephrol"},{"key":"4458_CR10","unstructured":"EUTox. The European Uremic Toxins (EUTox) database. Available online at www.uremic-toxins.org. Accessed 24 Aug 2022."},{"issue":"2","key":"4458_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/toxins13020142","volume":"13","author":"YJ Lim","year":"2021","unstructured":"Lim YJ, Sidor NA, Tonial NC, Che A, Urquhart BL. Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: mechanisms and therapeutic targets. Toxins. 2021;13(2):142. https:\/\/doi.org\/10.3390\/toxins13020142.","journal-title":"Toxins"},{"issue":"9","key":"4458_CR12","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.2215\/cjn.03150318","volume":"13","author":"RD Mair","year":"2018","unstructured":"Mair RD, Sirich TL, Plummer NS, Meyer TW. Characteristics of colon-derived uremic solutes. Clin J Am Soc Nephrol. 2018;13(9):1398\u2013404. https:\/\/doi.org\/10.2215\/cjn.03150318.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"4458_CR13","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.kint.2017.02.011","volume":"92","author":"E Mishima","year":"2017","unstructured":"Mishima E, Fukuda S, Mukawa C, Yuri A, Kanemitsu Y, Matsumoto Y, et al. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach. Kidney Int. 2017;92(3):634\u201345. https:\/\/doi.org\/10.1016\/j.kint.2017.02.011.","journal-title":"Kidney Int"},{"issue":"6","key":"4458_CR14","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.kint.2020.01.028","volume":"97","author":"T Gryp","year":"2020","unstructured":"Gryp T, De Paepe K, Vanholder R, Kerckhof FM, Van Biesen W, Van de Wiele T, et al. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease see. Kidney Int. 2020;97(6):1230\u201342. https:\/\/doi.org\/10.1016\/j.kint.2020.01.028.","journal-title":"Kidney Int"},{"key":"4458_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2021.116356","volume":"143","author":"JR Belinato","year":"2021","unstructured":"Belinato JR, Acquaro VR, Cappelini LTD, Augusto F. New prospects and problems in sample preparation methods for microbiome analysis. Trac-Trends Anal Chem. 2021;143: 116356. https:\/\/doi.org\/10.1016\/j.trac.2021.116356.","journal-title":"Trac-Trends Anal Chem"},{"key":"4458_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2021.116375","volume":"143","author":"LN Zhou","year":"2021","unstructured":"Zhou LN, Yu D, Zheng SJ, Ouyang RZ, Wang YT, Xu GW. Gut microbiota-related metabolome analysis based on chromatography-mass spectrometry. Trac-Trends Anal Chem. 2021;143: 116375. https:\/\/doi.org\/10.1016\/j.trac.2021.116375.","journal-title":"Trac-Trends Anal Chem"},{"key":"4458_CR17","doi-asserted-by":"publisher","unstructured":"Al Za\u2019abi M, Ali B, Al Toubi M. HPLC-fluorescence method for measurement of the uremic toxin indoxyl sulfate in plasma. J Chromatogr Sci. 2013;51(1):40-3. https:\/\/doi.org\/10.1093\/chromsci\/bms103.","DOI":"10.1093\/chromsci\/bms103"},{"issue":"23","key":"4458_CR18","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/j.jchromb.2011.06.014","volume":"879","author":"R Calaf","year":"2011","unstructured":"Calaf R, Cerini C, Genovesio C, Verhaeghe P, Jourde-Chiche N, Berge-Lefranc D, et al. Determination of uremic solutes in biological fluids of chronic kidney disease patients by HPLC assay. J Chromatogr B. 2011;879(23):2281\u20136. https:\/\/doi.org\/10.1016\/j.jchromb.2011.06.014.","journal-title":"J Chromatogr B"},{"issue":"6\u20137","key":"4458_CR19","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1007\/s00216-012-6277-z","volume":"404","author":"A Cuoghi","year":"2012","unstructured":"Cuoghi A, Caiazzo M, Bellei E, Monari E, Bergamini S, Palladino G, et al. Quantification of p-cresol sulphate in human plasma by selected reaction monitoring. Anal Bioanal Chem. 2012;404(6\u20137):2097\u2013104. https:\/\/doi.org\/10.1007\/s00216-012-6277-z.","journal-title":"Anal Bioanal Chem"},{"key":"4458_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.aca.2016.06.057","volume":"936","author":"H de Loor","year":"2016","unstructured":"de Loor H, Poesen R, De Leger W, Dehaen W, Augustijns P, Evenepoel P, et al. A liquid chromatography-tandem mass spectrometry method to measure a selected panel of uremic retention solutes derived from endogenous and colonic microbial metabolism. Anal Chim Acta. 2016;936:149\u201356. https:\/\/doi.org\/10.1016\/j.aca.2016.06.057.","journal-title":"Anal Chim Acta"},{"key":"4458_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.cca.2020.04.032","volume":"507","author":"N Fabresse","year":"2020","unstructured":"Fabresse N, Uteem I, Lamy E, Massy Z, Larabi IA, Alvarez JC. Quantification of free and protein bound uremic toxins in human serum by LC-MS\/MS: comparison of rapid equilibrium dialysis and ultrafiltration. Clin Chim Acta. 2020;507:228\u201335. https:\/\/doi.org\/10.1016\/j.cca.2020.04.032.","journal-title":"Clin Chim Acta"},{"key":"4458_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jpba.2019.01.041","volume":"167","author":"N Korytowska","year":"2019","unstructured":"Korytowska N, Wyczalkowska-Tomasik A, Wisniewska A, Paczek L, Giebultowicz J. Development of the LC-MS\/MS method for determining the p-cresol level in plasma. J Pharm Biomed Anal. 2019;167:149\u201354. https:\/\/doi.org\/10.1016\/j.jpba.2019.01.041.","journal-title":"J Pharm Biomed Anal"},{"issue":"11","key":"4458_CR23","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1681\/asn.2005030310","volume":"16","author":"AW Martinez","year":"2005","unstructured":"Martinez AW, Recht NS, Hostetter TH, Meyer TW. Removal of p-cresol sulfate by hemodialysis. J Am Soc Nephrol. 2005;16(11):3430\u20136. https:\/\/doi.org\/10.1681\/asn.2005030310.","journal-title":"J Am Soc Nephrol"},{"key":"4458_CR24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cca.2013.02.008","volume":"419","author":"CJ Pretorius","year":"2013","unstructured":"Pretorius CJ, McWhinney BC, Sipinkoski B, Johnson LA, Rossi M, Campbell KL, et al. Reference ranges and biological variation of free and total serum indoxyl- and p-cresyl sulphate measured with a rapid UPLC fluorescence detection method. Clin Chim Acta. 2013;419:122\u20136. https:\/\/doi.org\/10.1016\/j.cca.2013.02.008.","journal-title":"Clin Chim Acta"},{"key":"4458_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2020.113312","volume":"186","author":"ZP Wang","year":"2020","unstructured":"Wang ZP, Jiang H, Chen XJ, Song XH, Xu FJ, Chen FC, et al. A rapid and sensitive method for simultaneous determination of eight protein-bound uremic toxins in human serum by UHPLC-MS\/MS: application in assessing peritoneal dialysis. J Pharm Biomed Anal. 2020;186: 113312. https:\/\/doi.org\/10.1016\/j.jpba.2020.113312.","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"4458_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/chromsci\/bmw150","volume":"55","author":"LQ Gu","year":"2017","unstructured":"Gu LQ, Shi HY, Zhang RW, Wei Z, Bi KS, Chen XH. Simultaneous determination of five specific and sensitive nephrotoxicity biomarkers in serum and urine samples of four drug-induced kidney injury models. J Chromatogr Sci. 2017;55(1):60\u20138. https:\/\/doi.org\/10.1093\/chromsci\/bmw150.","journal-title":"J Chromatogr Sci"},{"issue":"8","key":"4458_CR27","doi-asserted-by":"publisher","first-page":"5207","DOI":"10.1021\/acs.analchem.8b05884","volume":"91","author":"L Whiley","year":"2019","unstructured":"Whiley L, Nye LC, Grant I, Andreas N, Chappell KE, Sarafian MH, et al. Ultrahigh-performance liquid chromatography tandem mass spectrometry with electrospray ionization quantification of tryptophan metabolites and markers of gut health in serum and plasma\u2014application to clinical and epidemiology cohorts. Anal Chem. 2019;91(8):5207\u201316. https:\/\/doi.org\/10.1021\/acs.analchem.8b05884.","journal-title":"Anal Chem"},{"issue":"2","key":"4458_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1053\/ajkd.2002.34518","volume":"40","author":"RM Fagugli","year":"2002","unstructured":"Fagugli RM, De Smet R, Buoncristiani U, Lameire N, Vanholder R. Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis. Am J Kidney Dis. 2002;40(2):339\u201347. https:\/\/doi.org\/10.1053\/ajkd.2002.34518.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"4458_CR29","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1093\/ndt\/gfr672","volume":"27","author":"N Meert","year":"2012","unstructured":"Meert N, Schepers E, Glorieux G, Van Landschoot M, Goeman JL, Waterloos MA, et al. Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications. Nephrol Dial Transplant. 2012;27(6):2388\u201396. https:\/\/doi.org\/10.1093\/ndt\/gfr672.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"4458_CR30","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1002\/jssc.202100950","volume":"45","author":"A Oda","year":"2022","unstructured":"Oda A, Suzuki Y, Sato B, Sato H, Tanaka R, Ono H, et al. Highly sensitive simultaneous quantification of indoxyl sulfate and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human plasma using ultra-high-performance liquid chromatography coupled with tandem mass spectrometry. J Sep Sci. 2022;45(10):1672\u201382. https:\/\/doi.org\/10.1002\/jssc.202100950.","journal-title":"J Sep Sci"},{"key":"4458_CR31","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jpba.2019.06.033","volume":"174","author":"AJ Prokopienko","year":"2019","unstructured":"Prokopienko AJ, West RE, Stubbs JR, Nolin TD. Development and validation of a UHPLC-MS\/MS method for measurement of a gut-derived uremic toxin panel in human serum: an application in patients with kidney disease. J Pharm Biomed Anal. 2019;174:618\u201324. https:\/\/doi.org\/10.1016\/j.jpba.2019.06.033.","journal-title":"J Pharm Biomed Anal"},{"issue":"22","key":"4458_CR32","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.1016\/j.chroma.2009.04.015","volume":"1216","author":"H de Loor","year":"2009","unstructured":"de Loor H, Meijers BKI, Meyer TW, Bammens B, Verbeke K, Dehaen W, et al. Sodium octanoate to reverse indoxyl sulfate and p-cresyl sulfate albumin binding in uremic and normal serum during sample preparation followed by fluorescence liquid chromatography. J Chromatogr A. 2009;1216(22):4684\u20138. https:\/\/doi.org\/10.1016\/j.chroma.2009.04.015.","journal-title":"J Chromatogr A"},{"issue":"1","key":"4458_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0009-8981(98)00124-7","volume":"278","author":"R De Smet","year":"1998","unstructured":"De Smet R, David F, Sandra P, Van Kaer J, Lesaffer G, Dhondt A, et al. A sensitive HPLC method for the quantification of free and total p-cresol in patients with chronic renal failure. Clin Chim Acta. 1998;278(1):1\u201321. https:\/\/doi.org\/10.1016\/s0009-8981(98)00124-7.","journal-title":"Clin Chim Acta"},{"key":"4458_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.talanta.2019.03.090","volume":"201","author":"XD Sun","year":"2019","unstructured":"Sun XD, Wu HL, Liu Z, Chen Y, Chen JC, Cheng L, et al. Target-based metabolomics for fast and sensitive quantification of eight small molecules in human urine using HPLC-DAD and chemometrics tools resolving of highly overlapping peaks. Talanta. 2019;201:174\u201384. https:\/\/doi.org\/10.1016\/j.talanta.2019.03.090.","journal-title":"Talanta"},{"issue":"3","key":"4458_CR35","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/ndt\/gfr453","volume":"27","author":"IW Wu","year":"2012","unstructured":"Wu IW, Hsu KH, Hsu HJ, Lee CC, Sun CY, Tsai CJ, et al. Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients\u2014a prospective cohort study. Nephrol Dial Transplant. 2012;27(3):1169\u201375. https:\/\/doi.org\/10.1093\/ndt\/gfr453.","journal-title":"Nephrol Dial Transplant"},{"key":"4458_CR36","unstructured":"European Medicines Agency. Guideline on bioanalytical method validation EMEA\/CHMP\/EWP\/192217\/2009. 2011."},{"key":"4458_CR37","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH guideline M10 on bioanalytical method validation EMA\/CHMP\/ICH\/172948\/2019, Step 2b, Draft version, 2019."},{"key":"4458_CR38","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jpba.2016.06.017","volume":"128","author":"R Thakare","year":"2016","unstructured":"Thakare R, Chhonker YS, Gautam N, Alamoudi JA, Alnouti Y. Quantitative analysis of endogenous compounds. J Pharm Biomed Anal. 2016;128:426\u201337. https:\/\/doi.org\/10.1016\/j.jpba.2016.06.017.","journal-title":"J Pharm Biomed Anal"},{"key":"4458_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jchromb.2014.11.001","volume":"976","author":"MS Gachet","year":"2015","unstructured":"Gachet MS, Rhyn P, Bosch OG, Quednow BB, Gertsch J. A quantitiative LC-MS\/MS method for the measurement of arachidonic acid, prostanoids, endocannabinoids, N-acylethanolamines and steroids in human plasma. J Chromatogr B. 2015;976:6\u201318. https:\/\/doi.org\/10.1016\/j.jchromb.2014.11.001.","journal-title":"J Chromatogr B"},{"key":"4458_CR40","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.microc.2019.04.075","volume":"148","author":"AI Barbosa","year":"2019","unstructured":"Barbosa AI, Fernandes SR, Machado S, Sousa P, Sze OY, Silva EMP, et al. Fast monolith-based chromatographic method for determination of methotrexate in drug delivery studies. Microchem J. 2019;148:185\u20139. https:\/\/doi.org\/10.1016\/j.microc.2019.04.075.","journal-title":"Microchem J"},{"issue":"18","key":"4458_CR41","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1039\/c8ay00327k","volume":"10","author":"PS Peixoto","year":"2018","unstructured":"Peixoto PS, Silva EMP, Os\u00f3rio MV, Barreiros L, Lima JLFC, Segundo MA. Automatic solid-phase extraction by programmable flow injection coupled to chromatographic fluorimetric determination of fluoroquinolones. Anal Methods. 2018;10(18):2180\u20136. https:\/\/doi.org\/10.1039\/c8ay00327k.","journal-title":"Anal Methods"},{"issue":"10","key":"4458_CR42","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1246\/cl.2000.1126","volume":"10","author":"N Ichinose","year":"2000","unstructured":"Ichinose N, Tojo S, Majima T. Fluorescence measurement of 3,5-dimethoxyphenol radical cation generated by pulse radiolysis in 1,2-dichloroethane. Chem Lett. 2000;10(10):1126\u20137. https:\/\/doi.org\/10.1246\/cl.2000.1126.","journal-title":"Chem Lett"},{"key":"4458_CR43","doi-asserted-by":"publisher","first-page":"117864691985212","DOI":"10.1177\/1178646919852120","volume":"12","author":"K-I Mawatari","year":"2019","unstructured":"Mawatari K-I, Atsumi M, Nakamura F, Yasuda M, Fukuuchi T, Yamaoka N, et al. Determination of dipicolinic acid in \u201cnatto\u201d by high-performance liquid chromatography coupled with postcolumn photoirradiation with zinc acetate. Int J Tryptophan Res. 2019;12:1178646919852120. https:\/\/doi.org\/10.1177\/1178646919852120.","journal-title":"Int J Tryptophan Res"},{"key":"4458_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2021.123046","volume":"238","author":"M Sajid","year":"2022","unstructured":"Sajid M, Plotka-Wasylka J. Green analytical chemistry metrics: a review. Talanta. 2022;238: 123046. https:\/\/doi.org\/10.1016\/j.talanta.2021.123046.","journal-title":"Talanta"},{"issue":"14","key":"4458_CR45","doi-asserted-by":"publisher","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","volume":"92","author":"F Pena-Pereira","year":"2020","unstructured":"Pena-Pereira F, Wojnowski W, Tobiszewski M. AGREE\u2014analytical greenness metric approach and software. Anal Chem. 2020;92(14):10076\u201382. https:\/\/doi.org\/10.1021\/acs.analchem.0c01887.","journal-title":"Anal Chem"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-022-04458-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00216-022-04458-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-022-04458-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T05:07:13Z","timestamp":1673586433000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00216-022-04458-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["4458"],"URL":"https:\/\/doi.org\/10.1007\/s00216-022-04458-w","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,5]]},"assertion":[{"value":"30 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee at <i>Centro Hospitalar de S\u00e3o Jo\u00e3o<\/i> (ref. CES 87\u201315) and performed in agreement with the 1964 Helsinki declaration and subsequent revisions. Written informed consent was obtained from all participants before sample collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}